CXCR4 and acute myeloid leukemia: Analysis of flow cytometric data showed that the CXCR4 expression was increased in FLT3‐ITD AML (10.48%, 0.55%‐74.98%) when compared with FLT3/wt AML (1.86%, 0.03%‐67.05%, P = .023).